Skip to main content

Table 2 Significantly dysregulated pathways predicted by pathway enrichment analysis

From: Integrative metabolomic profiling reveals aberrations in myometrium associated with adenomyosis: a pilot study

Pathway

Raw p

Impact

Hit metabolites

Purine metabolism

0.001

0.159

xanthine, phosphoribosyl formamidocarboxamide, adenylsuccinic acid, adenosine, inosine, adenine, hypoxanthine, guanine, 5-aminoimidazole ribonucleotide

Taurine and hypotaurine metabolism

0.020

0.353

taurine, 2-hydroxyethanesulfonate, pyruvic acid

Glycerophospholipid metabolism

0.026

0.204

citicoline, O-phosphoethanolamine, glycerylphosphorylethanolamine, CDP-ethanolamine

Nicotinate and nicotinamide metabolism

0.039

0.105

quinolinic acid, maleamate, NAD, pyruvic acid

Cysteine and methionine metabolism

0.081

0.172

5’-methylthioadenosine, S-adenosylhomocysteine, glutathione, pyruvic acid